Tempus AI diagnostics chief trades 2,694 shares at $70
Tempus AI, Inc. (TEM) reported an insider transaction by a company officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tempus AI, Inc. (TEM) reported an insider transaction by a company officer. On August 21, 2026, Thomas Edward Schoenherr, who serves as CEO, Diagnostics, reported a Form 4 transaction in Class A Common Stock involving 2,694 shares at $70.00 per share, with direct holdings reported at 87,021 shares following the transaction. The transaction is coded as a sale in the form fields but uses an acquisition flag in the SEC’s direction data, and it was carried out under a Rule 10b5-1 trading plan adopted on March 3, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1 | 2,694 | $70.00 | $189K |
Footnotes (1)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Class A Common Stock financial
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tempus AI, Inc. (TEM) report on this Form 4?
Who from Tempus AI, Inc. (TEM) is the reporting person on this Form 4?
What are the reported holdings of the insider in Tempus AI (TEM) after the transaction?
Was the Tempus AI (TEM) insider transaction under a Rule 10b5-1 trading plan?
How is the direction of the Tempus AI (TEM) insider transaction characterized?
AI-generated analysis. How Rhea-AI works. Not financial advice.